| Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ... The Lancet infectious diseases 18 (3), 318-327, 2018 | 6071 | 2018 |
| Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases LS Munoz-Price, L Poirel, RA Bonomo, MJ Schwaber, GL Daikos, ... The Lancet infectious diseases 13 (9), 785-796, 2013 | 1989 | 2013 |
| Genetic Structures at the Origin of Acquisition of the β-Lactamase blaKPC Gene T Naas, G Cuzon, MV Villegas, MF Lartigue, JP Quinn, P Nordmann Antimicrobial agents and chemotherapy 52 (4), 1257-1263, 2008 | 675 | 2008 |
| Acinetobacter Outbreaks, 1977–2000 MV Villegas, AI Hartstein Infection Control & Hospital Epidemiology 24 (4), 284-295, 2003 | 645 | 2003 |
| Antibiotic stewardship in low-and middle-income countries: the same but different? JA Cox, E Vlieghe, M Mendelson, H Wertheim, L Ndegwa, MV Villegas, ... Clinical microbiology and infection 23 (11), 812-818, 2017 | 495 | 2017 |
| First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing β-Lactamase MV Villegas, K Lolans, A Correa, JN Kattan, JA Lopez, JP Quinn Antimicrobial agents and chemotherapy 51 (4), 1553-1555, 2007 | 467 | 2007 |
| Worldwide diversity of Klebsiella pneumoniae that produce β-lactamase blaKPC-2 gene G Cuzon, T Naas, HV Truong, MV Villegas, KT Wisell, Y Carmeli, ... Emerging infectious diseases 16 (9), 1349, 2010 | 456 | 2010 |
| Acquisition of a natural resistance gene renders a clinical strain of methicillin‐resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid SM Toh, L Xiong, CA Arias, MV Villegas, K Lolans, J Quinn, AS Mankin Molecular microbiology 64 (6), 1506-1514, 2007 | 437 | 2007 |
| First Detection of the Plasmid-Mediated Class A Carbapenemase KPC-2 in Clinical Isolates of Klebsiella pneumoniae from South America M Virginia Villegas, K Lolans, A Correa, C Jose Suarez, JA Lopez, ... Antimicrobial agents and chemotherapy 50 (8), 2880-2882, 2006 | 417 | 2006 |
| The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae L Poirel, A Jayol, S Bontron, MV Villegas, M Ozdamar, S Türkoglu, ... Journal of Antimicrobial Chemotherapy 70 (1), 75-80, 2015 | 360 | 2015 |
| Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-γ in pleural fluid for the differential diagnosis of pleural tuberculosis MV Villegas, LA Labrada, NG Saravia Chest 118 (5), 1355-1364, 2000 | 296 | 2000 |
| A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail DA Goff, R Kullar, EJC Goldstein, M Gilchrist, D Nathwani, AC Cheng, ... The Lancet Infectious Diseases 17 (2), e56-e63, 2017 | 274 | 2017 |
| Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin A Jayol, L Poirel, A Brink, MV Villegas, M Yilmaz, P Nordmann Antimicrobial agents and chemotherapy 58 (8), 4762-4766, 2014 | 254 | 2014 |
| Mecanismos de resistencia a los antibióticos en bacterias Gram negativas JD Tafur, JA Torres, MV Villegas Infectio 12 (3), 227-232, 2008 | 250 | 2008 |
| Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective … M Wang, M Earley, L Chen, BM Hanson, Y Yu, Z Liu, S Salcedo, E Cober, ... The Lancet Infectious Diseases 22 (3), 401-412, 2022 | 216 | 2022 |
| Prevalence of extended-spectrum β-lactamases in South America MV Villegas, JN Kattan, MG Quinteros, JM Casellas Clinical Microbiology and Infection 14, 154-158, 2008 | 216 | 2008 |
| The epidemiology of carbapenemases in Latin America and the Caribbean K Escandón-Vargas, S Reyes, S Gutiérrez, MV Villegas Expert review of anti-infective therapy 15 (3), 277-297, 2017 | 187 | 2017 |
| Dissemination of Acinetobacter baumannii Clones with OXA-23 Carbapenemase in Colombian Hospitals MV Villegas, JN Kattan, A Correa, K Lolans, AM Guzman, N Woodford, ... Antimicrobial agents and chemotherapy 51 (6), 2001-2004, 2007 | 174 | 2007 |
| Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool M Sharland, S Gandra, B Huttner, L Moja, C Pulcini, M Zeng, ... The Lancet Infectious Diseases 19 (12), 1278-1280, 2019 | 167 | 2019 |
| Clinical and Microbiological Aspects of Linezolid Resistance Mediated by the cfr Gene Encoding a 23S rRNA Methyltransferase CA Arias, M Vallejo, J Reyes, D Panesso, J Moreno, E Castaneda, ... Journal of clinical microbiology 46 (3), 892-896, 2008 | 162 | 2008 |
